Syneron Medical (Syneron Medical) Interest Expense : $-0.9 Mil (TTM As of Mar. 2017)

View and export this data going back to 2004. Start your Free Trial

What is Syneron Medical Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Syneron Medical's interest expense for the three months ended in Mar. 2017 was $ -0.7 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.9 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Syneron Medical's Operating Income for the three months ended in Mar. 2017 was $ -3.9 Mil. Syneron Medical's Interest Expense for the three months ended in Mar. 2017 was $ -0.7 Mil. Syneron Medical did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Syneron Medical Interest Expense Historical Data

The historical data trend for Syneron Medical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneron Medical Interest Expense Chart

Syneron Medical Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Interest Expense

Get a 7-Day Free Trial

-0.27

-0.25

-0.07

-0.22

Syneron Medical Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Interest Expense	Get a 7-Day Free Trial															-	-	-	-0.18	-0.74

Syneron Medical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.9 Mil.

Syneron Medical (NAS:ELOS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Syneron Medical's Interest Expense for the three months ended in Mar. 2017 was $-0.7 Mil. Its Operating Income for the three months ended in Mar. 2017 was $-3.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2017 was $0.0 Mil.

Syneron Medical's Interest Coverage for the quarter that ended in Mar. 2017 is calculated as

Syneron Medical did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Syneron Medical (Syneron Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Syneron Medical Ltd (NAS:ELOS) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.syneron.com

Syneron Medical Ltd., was incorporated in the State of Israel in July 2000. The Company completed its initial public offering of ordinary shares in August 2004. It designs, develops and markets aesthetic medical products based on its various technologies including its proprietary Electro-Optical Synergy, or ELOS, technology, which uses the synergy between electrical energy, including radiofrequency or RF energy, and optical energy to provide effective, safe and affordable aesthetic medical treatments. The Company's products, which it sells mainly to physicians and other practitioners, target non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin and laser-assisted lipolysis and topical skin brightening products.

Executives

North Tide Capital, Llc	10 percent owner	500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
Laughlin Conan	director, 10 percent owner	C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
North Tide Capital Master, Lp	10 percent owner	C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116

Syneron Medical (Syneron Medical) Headlines

From GuruFocus

Why Is Seth Klarman Loading Up on Syneron Medical?

By matsandalex matsandalex • 08-29-2011

Seth Klarman More Than Doubles Holdings in Syneron Medical

By teddycx teddycx • 07-12-2011

Top Seth Klarman Holding, ELOS Rockets Up 20%

By matsandalex matsandalex • 02-17-2011

Seth Klarman Buys First American Corp., Universal Compression Holdings, School Specialty Inc., Sells Courtside Acquisition Corp, Healthsouth Corp.

By gurufocus • 08-13-2007